Articles tagged with Melanoma
A new mouse model has been developed to induce melanoma with a defined cancer antigen, closely mimicking human tumors. This model allows for detailed immunological analyses before and after vaccination, which may lead to a better understanding of spontaneous melanoma regressions and the optimization of cancer vaccine timing.
Counseling pediatricians on skin cancer prevention is crucial, as childhood sun exposure increases the risk of melanoma. UV light from natural sunlight and artificial sources like tanning beds also pose risks.
The incidence of invasive melanoma has significantly increased among Hispanic males in California between 1988 and 2001. The rate of invasive tumors greater than 0.75mm thick is particularly concerning, with a notable increase among Hispanic men compared to non-Hispanic whites.
A study found that nearly half of patients treated with the PC combination experienced a clinical benefit, including stable disease and tumor size reduction. Researchers believe this combination has a beneficial role, especially for patients with poor treatment outcomes.
A study by Northwestern University found that postmenopausal white women with a history of non-melanoma skin cancer are twice as likely to develop cutaneous melanoma. Regular skin checkups are crucial for these high-risk individuals to reduce the incidence of deadly melanoma.
A global skin cancer research consortium, Genomel, has won £7m in funding to investigate the genetics of melanoma and identify those at high risk. The project will also develop a website providing information on melanoma symptoms, diagnosis, and treatment.
A new study found that radiation therapy can effectively control primary tumors and spare vision in patients with uveal melanoma. The procedure involves plaque radiotherapy, which delivers radiation to the eye tumor via a small metal shield containing radioactive seeds.
Researchers found that individuals carrying CDKN2A mutations have a significantly higher risk of developing melanoma by age 50 (14%), 70 (24%), and 80 (28%). Genetic testing is unlikely to identify many mutation carriers due to the modest impact of these mutations on population incidence.
A research team at the University of Montreal has developed a cancer-curing therapy using T-lymphocytes, which recognize and destroy abnormal cells. The treatment targets specific antigens found on cancer cells, producing interferon gamma and perforine/granzyme to eradicate tumors without causing side effects.
A study published in JAMA found that patients with melanoma are at a higher risk of developing multiple primary melanomas. The study identified characteristics of patients at risk and estimated the five-year risk of MPM to be significantly higher for those with positive family history or dysplastic nevi.
A study of 4,484 patients with first primary melanomas found that 8.6% had multiple primary melanomas, with a higher risk for those with family history or dysplastic nevi. The estimated cumulative 5-year risk of a second primary tumor was 11.4%, with a significant increase in incidence for the development of third primary melanoma.
Renal transplant recipients are 3.6 times more likely to develop melanoma than the general population, with a mortality rate up to 6 percent in some regions. Men who have had a kidney transplant face the greatest risk, and risk increases rapidly with age.
Renal transplant recipients are at increased risk for melanoma due to immunosuppression, with a 3.6-fold increase in incidence compared to the general population. The risk increases five percent per year after transplantation and is greater in men, who also experience rapid age-related increases.
Dr. Gragoudas is being recognized for his groundbreaking work on protein beam irradiation and photodynamic therapy for intraocular melanoma and neovascular age-related macular degeneration. He has made significant contributions to the clinical practice of ophthalmology, particularly in the study of retinal vascular diseases.
A study by researchers at the University of Michigan Health System found that patients learned more facts from educational videos than from their doctors during a clinic visit. However, the video was less effective in reducing anxiety and stress levels compared to face-to-face interactions with their doctors.
Researchers at the University of Texas M. D. Anderson Cancer Center discovered that curcumin stops laboratory strains of melanoma from proliferating by shutting down nuclear factor-kappa B (NF-kB). The spice also induces apoptosis, or programmed death, in cancer cells.
The Sydney Melanoma Unit has been awarded a National Health and Medical Research Council Program Grant, providing $7.8 million to support its vital research. The grant aims to identify molecular factors that determine an individual's risk of melanoma and develop more effective treatments.
A new study found long-duration regular use of aspirin or NSAIDs may lower prostate cancer risk by 18%. Gene variants associated with melanoma risk were also identified in a Mediterranean population study, while another study found no link between gene mutations and response to bevacizumab
The number of new melanoma cases in the US increased 60% from 1988-1991 to 1996-1999, with thick melanomas primarily composed of nodular subtype. The study suggests that current early-detection educational programs may not be effective for detecting this aggressive type of melanoma.
Patients with a personal or family history of melanoma exhibit similar sunbathing patterns and protective measures to low-risk populations, highlighting the need for improved education and awareness campaigns.
A study assessed dermatologists' perception of 4,036 skin lesions and found that irregularity, ugly duckling sign, and recent change are key factors. These findings suggest that teaching the public to recognize these patterns could improve early detection of melanoma.
Archaeological findings reveal extensive ancient Maya salt workshops beyond royal control, while researchers investigate the role of Toll-like receptor 4 in inducing neuropathic pain. Atmospheric pollution is linked to wheat disease prevalence, and microarray technology helps diagnose skin cancer stages. Serotonin levels may regulate e...
Researchers discovered that targeting mutant B-Raf protein can prevent the spread of melanoma and halt tumor growth. Lowering mutant B-Raf activity reduced melanoma development in human cells, providing a potential breakthrough for treating this aggressive form of skin cancer.
Researchers genetically engineered zebrafish to develop black-pigmented moles with mutated human BRAF and p53 genes. The study shows that BRAF mutations are necessary for mole development, but insufficient for cancer. The model provides insights into how gene mutations contribute to melanoma
Researchers have developed a zebrafish model that shows human BRAF mutations can induce dramatic black pigmentation and aggressive melanomas. The study also found that p53 deficiency is crucial for melanoma development, providing new insights into melanoma genetics and drug development.
Research findings indicate that increased sun exposure is associated with improved melanoma survival, while decreased UV radiation exposure may lower non-Hodgkin lymphoma risk. These studies provide new evidence for the potential beneficial effects of sunlight on cancer incidence and outcome.
Researchers expand the ABCD rule to recognize changing characteristics of early melanomas, especially nodular melanomas. The new guideline aims to improve detection and diagnosis of this aggressive form of skin cancer.
PET scans improved detecting distant metastases with an accuracy of 85%, compared to 55% for current standard diagnostics. The technique also showed high accuracy in diagnosing locoregional disease, surpassing current practice by 24 percentage points.
The combination of BAY 43-9006 and standard chemotherapy showed durable partial responses in 40% of patients with advanced metastatic melanoma. The study demonstrated anti-tumor activity that was not solely dependent on a BRAF gene mutation, offering new hope for treatment options.
Researchers found tumor disappearance and shrinking in four out of nine patients with advanced melanoma treated with CP-675,206. The antibody works by blocking a negative regulator of the immune system, allowing it to attack cancer cells. A Phase II study is now underway to further investigate the treatment.
A phase II multicenter study evaluated a multiepitope CD8 T-cell vaccine for metastatic melanoma patients, demonstrating an immune response associated with longer survival. The vaccine showed promising results in stimulating an immune response, but no correlation was found with clinical tumor responses.
Researchers discovered feasible chemotherapy combinations that include trastuzumab for HER2-positive advanced breast cancer, with higher overall response rates and lower cardiac dysfunction. Two phase II clinical trials showed promising results, paving the way for future randomized phase III trials.
Researchers found that digital photographs improved detection of new or changed moles, increasing accuracy by over 10% compared to skin self-examinations alone. Baseline photography may effectively improve diagnostic accuracy in patients performing skin self-examinations.
The American College of Physicians released guidelines for treating atrial fibrillation, an abnormal heart rhythm that can lead to stroke if uncontrolled. Researchers also reviewed 18 studies on melanoma and sunscreen use, finding no link between the two conditions.
A new study published in the Journal of Clinical Oncology found that low-dose interferon therapy did not extend overall or recurrence-free survival in high-risk melanoma patients. The trial involved 674 patients and found that both groups experienced similar rates of disease recurrence and mortality.
A recent study has identified a genetic risk factor for malignant melanoma in men, highlighting the importance of faulty genes in the development of the disease. The study found that variants in the BRAF gene are more common in people with melanoma, particularly in men.
A new peptide-based vaccine has shown promising results in treating advanced melanoma by inducing a strong immune response in patients. The vaccine, which includes granulocyte macrophage-colony stimulating factor (GMCSF), resulted in significant tumor regressions and stable disease in some patients.
The American Academy of Ophthalmology has published several new studies on various eye conditions, including amblyopia, glaucoma, and corneal surgery. Researchers have explored the effectiveness of patching regimens for treating severe amblyopia in children and found promising results.
Researchers developed a new method to detect melanoma in lymph nodes using molecular analysis, revealing 25% of cancer-free patients had undetectable metastases. The study found patients with multiple markers were more likely to develop recurrence and die from the disease.
A study by cancer nurse Kerry Guile found that even oncologists and cancer nurses with high knowledge of sun protection were not acting on it. The sample size was 340 people, including medical students and non-oncology nurses, who scored highly on sun protective behavior.
Experts warn that taxing tanning may lead to increased use of indoor tanning beds among teens, who already receive too little UV light. The lack of proper sunscreen use is a major concern for public health.
Researchers are exploring alternative methods to conventional medical care for treating women's health issues, antibiotic-resistant infections, melanomas, and coronary heart disease. Nutritional and botanical therapies are being investigated as potential alternatives to traditional treatments.
Researchers found NRAS mutations in 95% of primary hereditary melanomas, but only 10% of sporadic melanomas. The study suggests a link between UV light exposure and the activation of NRAS mutations in early stages of melanoma development.
A phase II study of a multiepitope CD8 T-cell vaccine has demonstrated promising results, inducing an immune response in 32% of patients with metastatic melanoma. The vaccine showed significant correlations with non-progression of disease and longer survival rates.
A new study suggests that PTEN dysfunction is responsible for 30-60% of melanomas and offers a potential therapeutic approach to kill cancer cells. The introduction of PTEN into melanoma cells could be a useful treatment option, but the cancer cells may eventually learn to evade this approach.
A Rutgers researcher has discovered a gene that causes melanoma by expressing differently in skin cells compared to brain cells. The finding provides new insights into the disease's development and could lead to more targeted treatments.
Researchers at Memorial Sloan-Kettering Cancer Center have developed a DNA-based vaccine that triples the survival rate for dogs with advanced melanoma. The vaccine, tested in nine dogs with no side effects, shows promise for treating this aggressive cancer in humans.
Researchers have discovered a specific molecular pathway within cells that becomes mutated by ultraviolet light exposure, accelerating melanoma development. The study's findings suggest a rational method for risk stratification and screening of atypical skin moles, which could help identify patients with high-risk profiles.
A new study reveals that sentinel lymph node mapping can be safely performed on patients with melanoma in the delicate head and neck area, allowing for early detection of cancer spread. The technique has been shown to accurately stage patients and identify those who need further treatment, potentially improving survival rates.
A recent study by the American Association for Cancer Research found that patients with advanced melanoma expressing higher levels of melanoma-associated antigens (MAAs) experienced significantly improved survival outcomes. The study suggests that these tumors may be more responsive to immunotherapy, such as vaccines against melanoma.
A study by Emory University scientists identified the MAP kinase signaling pathway as a key player in early melanoma development. The researchers found that this pathway is abnormally activated in early melanomas, but not in precancerous moles. This finding has implications for diagnosis and treatment of melanoma.
A study published in the Journal of the National Cancer Institute found that higher levels of the molecule HDM2 are associated with a better prognosis in patients with melanoma. Patients with high levels of HDM2 lived significantly longer after treatment than those with low levels, even ten years after diagnosis.
A study recalculated cancer incidence rates from SEER data and found significant percentage changes (3-14%) between reporting-adjusted and unadjusted rates. The authors emphasize the importance of considering these corrections to accurately monitor trends in cancer incidence.
The study found that mortality from melanoma remained relatively stable in Scotland between 1979 and 1993, with a slight decrease in women under 65. Meanwhile, the number of people diagnosed with melanoma has increased each year. The researchers attribute the decline in death rates to improved treatment seeking behavior.
A study found that genetic mutation penetrance for melanoma varies by geographic location, with higher risks in countries like the US and Australia. Researchers suggest environmental factors contribute to this variation, contradicting previous assumptions about gene mutations and their impact on disease expression.
A recent study found that most popular melanoma web sites had incomplete facts about the disease, with around one in eight sites having inaccuracies. The study suggests that Web users should be cautious when searching for health information online and guide themselves toward reputable sources.
A genetic mutation known as Id1 may help detect melanoma early, when it's still curable. High levels of Id1 are found only in the first stages of melanoma, making it a potential diagnostic marker.
Researchers found that survival rates for primary eye cancer treatments are essentially the same, with a five-year survival rate of 82% for both radiation therapy and eye removal. The study's findings expand the capability of doctors to provide accurate diagnoses and state-of-the-art treatments.
A recent study by Ohio State University found that survival rates are similar for patients with choroidal melanoma who undergo radiation therapy or have their affected eye removed. The study, which involved 1,317 patients, showed that both treatment options result in high five-year survival rates.
Researchers found that malignant melanomas often lose the protein Apaf-1, leading to resistance to chemotherapy drug adriamycin. Restoring Apaf-1 in melanoma cells rescues their ability to kill themselves in response to adriamycin.